Today, on #WorldCancerDay, we're launching EveryDoseMatters: a global cancer safety campaign that aims to help patients and healthcare providers prevent, detect and respond to fake cancer medicines. Are you a healthcare provider or cancer patient? Visit https://t.co/9UBMuo9Meg.
A child's chances of surviving cancer should not be determined by where they live. Yet, low quality cancer medicines often reach children in the poorest countries.
Read about the 2023 investigation of contaminated asparagine, a treatment for leukaemia: https://t.co/9nEVfaiLjh
Cancer patients in India were exposed to falsified Keytruda in a recent counterfeit scheme. As incidents become common, education can play an important role. Our CME course was designed to train healthcare professionals to address this evolving crisis: https://t.co/GevPbVo9dt
Would you recognize a falsified cancer medicine before it reaches your patient?
🏫Our new CME course equips healthcare providers with the skills needed to identify, report and communicate with patients about unsafe cancer medicines.
Register here: https://t.co/g6kEfNaMeL
On #WorldHealthDay, we're standing with science by working with patients and healthcare providers to ensure cancer medicines are safe, effective, and trusted. 💊
ℹ️ https://t.co/t477BnfbEp
When cancer patients fall victim to fake medicines, the harm doesn’t stop at their health.
Patients also lose trust in the health system and their peace of mind.
Maxine Blount's story illustrates the pain and stress of exposure to fake medicines.
ℹ️:https://t.co/t477BnfbEp
We're joining the @pahowho in calling for strengthened response to substandard and falsified medical products (SFMPs)!
Whether you are a patient or a health provider, your quick response to suspected SFMPs can significantly reduce public health harm.
📢 March 17–19: Joining a regional effort across the Americas to raise awareness on substandard & falsified medical products.
BESAFE remains committed to strengthening awareness and systems globally.
#PAHO#SafeMedicines#FightFalsifiedProducts
Healthcare providers and cancer patients: Are you taking steps to ensure you’re receiving an authentic medicine? Here are 4 simple steps you can take that support safer cancer care💊⬇️
Substandard and falsified drugs are an increasingly widespread threat to global health. Expensive medicines that are prone to shortages, such as cancer therapies, may be a target for counterfeiters due to their high profit potential. There are concerns that healthcare providers lack knowledge of these threats and how to identify and report suspicious drugs.
Read this scoping review into healthcare providers' knowledge gaps and educational needs in our sister journal, BMJ Connections Oncology
🔗 https://t.co/tm4MYdbedb
🔔ISoP Webinar - Members Only
Substandard and falsified medicines remain underreported globally.
Prof. Saifuddin Ahmed (PI, BESAFE, Johns Hopkins) joins experts to discuss practical strategies to close the reporting gap.
Register Now: https://t.co/DvpJvYUj2R
@ISoPonline
💊 Countering Counterfeits: The Role of Nurse Practitioners
A Johns Hopkins survey found:
⚠️ 89% don’t know how to act
⚠️ 80% don’t see counterfeits as serious
New JAANP editorial calls nurse practitioners to act:
:https://t.co/yDkwNg3hDm
💊 Momentum is building for #BESAFE2025!
Join experts from public health, regulation, industry, and beyond to strengthen medicine quality, protect patients, and advance safer health systems.
Register now: https://t.co/pYU2UY8HaY
@FPI_SAIS@JohnsHopkinsSPH@HopkinsPFRH
#
🏥In a new article published in Uppsala Reports, BESAFE's Saifuddin Ahmed and others discuss the current state of pharmacovigilance systems globally, highlighting weaknesses, opportunities and potential solutions.
https://t.co/8GgZuEeVmm